Mucosal Immunization with Recombinant Adenovirus Encoding Soluble Globular Head of Hemagglutinin Protects Mice Against Lethal Influenza Virus Infection |
Kim, Joo Young
(Graduate School of Pharmaceutical Sciences, Ewha Womans University)
Choi, Youngjoo (Graduate School of Pharmaceutical Sciences, Ewha Womans University) Nguyen, Huan H. (Laboratory Science Division, International Vaccine Institute) Song, Man Ki (Laboratory Science Division, International Vaccine Institute) Chang, Jun (Graduate School of Pharmaceutical Sciences, Ewha Womans University) |
1 | Wilson, I. A. and N. J. Cox. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8: 737-771. DOI ScienceOn |
2 | Brandtzaeg, P. 2003. Role of secretory antibodies in the defence against infections. Int. J. Med. Microbiol. 293: 3-15. DOI ScienceOn |
3 | Gao, W., A. C. Soloff, X. Lu, A. Montecalvo, D. C. Nguyen, Y. Matsuoka, P. D. Robbins, D. E. Swayne, R. O. Donis, J. M. Katz, S. M. Barratt-Boyes, and A. Gambotto. 2006. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80: 1959-1964. DOI ScienceOn |
4 | Hoelscher, M. A., S. Garg, D. S. Bangari, J. A. Belser, X. Lu, I. Stephenson, R. A. Bright, J. M. Katz, S. K. Mittal, and S. Sambhara. 2006. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet 367: 475-481. DOI ScienceOn |
5 | Van Kampen, K. R., Z. Shi, P. Gao, J. Zhang, K. W. Foster, D. T. Chen, D. Marks, C. A. Elmets, and D. C. Tang. 2005. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23: 1029-1036. DOI ScienceOn |
6 | Vemula, S. V. and S. K. Mittal. 2010. Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opin. Biol. Ther. 10: 1469-1487. DOI ScienceOn |
7 | Yu, J. R., S. Kim, J. B. Lee, and J. Chang. 2008. Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J. Virol. 82: 2350-2357. DOI ScienceOn |
8 | Zhu, J., X. Huang, and Y. Yang. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor- dependent and -independent pathways. J. Virol. 81: 3170-3180. DOI ScienceOn |
9 | Nociari, M., O. Ocheretina, J. W. Schoggins, and E. Falck- Pedersen. 2007. Sensing infection by adenovirus: Toll-like receptor- independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 81: 4145-4157. DOI ScienceOn |
10 | Domm, W., L. Brooks, H. L. Chung, C. Feng, W. J. Bowers, G. Watson, J. L. McGrath, and S. Dewhurst. 2011. Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier. Vaccine 29: 7080-7089. DOI ScienceOn |
11 | Appledorn, D. M., Y. A. Aldhamen, S. Godbehere, S. S. Seregin, and A. Amalfitano. 2011. Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 immunity. Clin. Vaccine Immunol. 18: 150-160. DOI |
12 | Brandtzaeg, P. and R. Pabst. 2004. Let's go mucosal: communication on slippery ground. Trends Immunol. 25: 570- 577. DOI ScienceOn |
13 | Suzuki, K. and S. Fagarasan. 2008. How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol. 29: 523-531. DOI ScienceOn |
14 | Ichinohe, T., A. Iwasaki, and H. Hasegawa. 2008. Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev. Vaccines 7: 1435-1445. DOI ScienceOn |
15 | Yuki, Y. and H. Kiyono. 2003. New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 13: 293-310. DOI ScienceOn |
16 | Kunkel, E. J. and E. C. Butcher. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3: 822-829. DOI ScienceOn |
17 | Mutsch, M., W. Zhou, P. Rhodes, M. Bopp, R. T. Chen, T. Linder, C. Spyr, and R. Steffen. 2004. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350: 896-903. DOI ScienceOn |
18 | Cuburu, N., M. N. Kweon, J. H. Song, C. Hervouet, C. Luci, J. B. Sun, P. Hofman, J. Holmgren, F. Anjuere, and C. Czerkinsky. 2007. Sublingual immunization induces broadbased systemic and mucosal immune responses in mice. Vaccine 25: 8598-8610. DOI ScienceOn |
19 | Song, J. H., H. H. Nguyen, N. Cuburu, T. Horimoto, S. Y. Ko, S. H. Park, C. Czerkinsky, and M. N. Kweon. 2008. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc. Natl. Acad. Sci. U. S. A. 105: 1644-1649. DOI ScienceOn |
20 | Kweon, M. N. 2011. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. Cytokine 54: 1-5. DOI ScienceOn |
21 | Collin, N. and X. de Radigues. 2009. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27: 5184-5186. DOI ScienceOn |
22 | Shirakawa, T. 2009. Clinical trial design for adenoviral gene therapy products. Drug News Perspect. 22: 140-145. DOI ScienceOn |
23 | Shim, B. S., Y. K. Choi, C. H. Yun, E. G. Lee, Y. S. Jeon, S. M. Park, I. S. Cheon, D. H. Joo, C. H. Cho, M. S. Song, S. U. Seo, Y. H. Byun, H. J. Park, H. Poo, B. L. Seong, J. O. Kim, H. H. Nguyen, K. Stadler, D. W. Kim, K. J. Hong, C. Czerkinsky, and M. K. Song. 2011. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PLoS One 6: e27953. DOI ScienceOn |
24 | He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95: 2509-2514. DOI ScienceOn |
25 | Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166. DOI ScienceOn |
26 | Croyle, M. A., A. Patel, K. N. Tran, M. Gray, Y. Zhang, J. E. Strong, H. Feldmann, and G. P. Kobinger. 2008. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS One 3: e3548. DOI ScienceOn |
27 | van Ginkel, F. W., R. J. Jackson, Y. Yuki, and J. R. McGhee. 2000. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165: 4778-4782. DOI |